Old World Labs

"The mini-labs provide a flexible test environment that delivers real measurement data," Gamella said in a statement. "They're a bit like a playground for algorithms, where researchers can test their AI beyond simulated data in a controlled and safe environment."

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Mycotoxins have long been a pervasive challenge in agriculture and food production, threatening both animal and human health. As naturally occurring

The tech platform said producers can better detect contamination and allergens with its program in order to achieve compliance.

Western companies' one-size-fits-all AI strategies don't serve many of the world's populations. These African researchers are working to change that.

ReviewAI, a product developed by St. John's-based tech company CoLab Software, can comb through data and knowledge of past engineering projects to provide insight, improvements and make sure mistakes found in the past aren't repeated.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.